Patients Presenting With Suspicion of Infection to the ED Clinical Trial
Official title:
Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using Midregional Proadrenomedullin (MR-proADM) - Pilot Study
Emergency departments (ED) are becoming increasingly over-crowded, with patients facing
prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with
low severity that could be treated as outpatients is essential for improving the workflow
within the ED.
The rationale of this IDEAL study is to provide guidance to safely decrease the number of
hospital admissions through identification of low risk patients with the biomarker MR-proADM.
This will be tested in a pilot study first.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05108883 -
Risk Stratification Using Midregional Proadrenomedullin in the ED
|
N/A |